Bayer digitised pharmacovigilance data-request processes on the Appian platform.
Decades of isolated IT systems forced manual compilation of data from several sources for pharmacovigilance reporting. Bayer used the Appian platform to automate recurring decisions, add mobile approvals and real-time KPI tracking. The page says staff can redirect time to higher-value work, and gives no numeric result.
Appian is a low-code process automation platform with AI agents, used by pharma for pharmacovigilance, regulatory and compliance workflows
This sits in the Ship stage of the AI use-case lifecycle: Named examples from the vendors pharma teams use to get an AI system live inside a real, regulated production workflow — validation, CRM, safety and clinical systems of record.
Published by Appian on its own site — read the original case study on appian.com ↗
Note: Older press item; no quantified results.
Related use cases
- 01Transforming Content Operations for 2x Faster Time to Market
- 02Astellas: Breaking Access Barriers with Veeva Compliant Chat
- 03How Pacira Generated Deep Website Insights to Get Patients on Therapy Faster
- 04Reaching Underserved Communities with Smarter Targeting
- 05Building Agile Territory Strategies to Scale Pre-Commercial Field Teams
- 06How Alfasigma Unified Regulatory Data and Processes for Cross-Functional Alignment